Barrett’s Esophagus

Barrett's Esophagus

With Barrett’s esophagus, the tissue lining the lower esophagus (the tube that transports food from the throat to the stomach) becomes damaged. The condition is usually caused by chronic regurgitation of stomach acid, also know as Gastroesophageal Reflux Disease (GERD).

Because Barrett’s esophagus is linked to increased risk for developing esophageal cancer, routine monitoring is normally conducted to find precancerous or cancerous cells early. Early detection is vital to survival. The condition is more prevalent in men, and while symptoms often mimic those of acid reflux, many patients have no symptoms at all.

New Jersey gastroenterologist Dr. Howard N. Guss has extensive experience in diagnosing and treating Barrett’s esophagus, and was one of the first gastroenterologists in the state to provide Barrx  Halo ablation, a new advanced therapy for Barrett’s esophagus. Barrx  is highly recommended by the American Gastroenterological Association and uses radiofrequency energy to safely remove or destroy abnormal esophageal tissue, while minimizing injury to surrounding healthy tissue. The procedure is performed under anesthesia and delivers a controlled amount of energy to the esophagus via a catheter—an endoscope-mounted catheter to treat small areas of Barrett’s disease, and a balloon-mounted catheter for large areas.

Symptoms of Barrett’s Esophagus:

  • Heartburn
  • Those related to GERD

Treatments of Barrett’s Esophagus:

  • Routine monitoring
  • Avoiding dietary fats, chocolate, caffeine, alcohol and tobacco
  • Losing weight
  • Sleeping with the head elevated
  • Medications (proton pump inhibitors such as Dexilant or Nexium, antacids, histamine H2 receptor blockers, promotility agents)
  • Endoscopy – Upper Endoscopy
  • Photodynamic therapy
  • Barrx  radiofrequency ablation
  • Surgery to remove abnormal lining